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Potential Effect Modifiers of the Association
Between Physical Activity Patterns and Joint
Symptoms in Middle-Aged Women
GEESKE PEETERS,1 KIMBERLEY L. EDWARDS,2 WENDY J. BROWN,3 ANNA L. BARKER,4 NIGEL ARDEN,5
ANTHONY C. REDMOND,6 PHILIP G. CONAGHAN,6 FLAVIA CICUTTINI,4 AND GITA D. MISHRA7
Objective. To examine whether body mass index (BMI), menopausal status, and hormone therapy (HT) use modify the
association between physical activity (PA) patterns throughout middle age and the incidence and prevalence of joint
symptoms in women in later middle age.
Methods. Data were from 6,661 participants (born 1946–1951) in the Australian Longitudinal Study on Women’s
Health. Surveys, with questions on joint pain and stiffness, PA, height and weight, menopausal symptoms, and HT
use, were completed every 3 years from 1998 to 2010. PA patterns were defined as none or low, low or meeting guide-
lines, fluctuating, or meeting guidelines at all times (reference pattern). Logistic regression was used to examine the
association between PA patterns and prevalent (in 2010) and cumulative incident (1998–2010) joint symptoms and
effect modification by patterns in BMI, menopausal status, and HT.
Results. The groups representing fluctuating PA (odds ratio [OR] 1.34 [99% confidence interval (99% CI) 1.04–1.72]) and no or
low PA (OR 1.60 [99% CI 1.08–2.35]) had higher odds of incident joint symptoms than those described as meeting guidelines at
all times. Stratification by BMI showed that this association was statistically significant in the obese group only. No evidence
for effect modification by menopausal status or HT use was found. The findings were similar for prevalent joint symptoms.
Conclusion. Maintaining at least low levels of PA throughout middle age was associated with a lower prevalence and
incidence of joint symptoms later in life. This apparent protective effect of PA on joint symptoms was stronger in obese
women than in under- or normal-weight women, and not related to menopause or HT status.
INTRODUCTION
Middle age has been suggested to be a pivotal time for inter-
ventions to prevent chronic conditions, such as osteoarthri-
tis (OA), whose incidence increases after the age of 50 years
(1). Given its beneficial effects on cartilage health, physical
activity (PA) is believed to be an important modifiable risk
factor for OA (2). The complexity of the association
between PA and OA is illustrated by findings suggesting
that PA may have both protective and damaging effects on
different joint structures (2). Despite decades of research,
many aspects of the relationship between PA and OA-
related joint symptoms remain unclear (3). A better under-
standing of potential modifiers of the association between
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PA and joint symptoms may provide new insights into the
etiology and guide the tailoring of preventive interventions.
A study that followed middle-aged women over a period of
12 years showed that being physically active at ages 52–58
years, but not at ages 47–52 years, reduced the risk of new-
onset joint symptoms in later middle age (4). The change in
the association between PA and joint symptoms coincided
with menopause (5). Premenopausal women may benefit
from the protective effects of estrogen on joint structures and
via the inflammation pathway (6). When estrogen levels
decrease during the menopausal transition, inflammatory
markers increase (7). The increase in inflammatory markers is
partly explained by changes in fat mass (7). Low-grade inflam-
mation may affect joint structures via multiple pathways (8).
There is some evidence that PA and body composition may
influence the postmenopausal increase in inflammatory
markers (7), and vice versa; menopause and body composi-
tion maymodify the effects of PA on joint structures.
If estrogen has protective effects on joint structures, one
would expect beneficial effects to arise from hormone ther-
apy (HT) and detrimental effects following hysterectomy
and oophorectomy. Hysterectomy and oophorectomy have
been associated with an increased risk of OA (9–11). Evi-
dence for an association between HT use and OA is incon-
clusive, however. Some (9,12), but not all (12–14),
observational studies found that HT use had significant
protective associations with (radiographic) OA. In the stud-
ies that did not find statistically significant associations,
the odds ratios were suggestive of protective associations of
HT use, but the studies seemed underpowered to detect
these (12–14). In contrast, other observational studies found
that HT use was associated with increased risks of hip and
hand, but not knee OA (15) or hip and knee replacement
(16). Results from randomized controlled trials suggest that
estrogen-only therapy, but not estrogen plus progestin ther-
apy, may be associated with reduced risks of joint replace-
ment and joint symptoms (17–19).
In summary, there is a complex interplay between PA,
body composition, and menopause and the risk of devel-
oping OA. Previous studies have typically examined PA
at one point in time with outcomes measured at a later
point in time. This approach does not account for the
fluctuations in PA behavior over time (20). The aim of
this prospective cohort study was to examine whether
body composition, menopausal status, and use of HT
modify the association between PA patterns throughout
middle age and the incidence and prevalence of joint
symptoms in later middle age in women.
MATERIALS AND METHODS
Participants. Data were from the middle-aged cohort
(born 1946–1951) in the Australian Longitudinal Study on
Women’s Health (ALSWH), a prospective study of the health
and well-being of women (21). The sample was randomly
drawn from the national Medicare health insurance database,
which includes all Australian citizens and permanent
residents, with intentional overrepresentation of women from
rural and remote areas (21,22). More details about the study
can be found at www.alswh.org.au. The study was approved
by the Ethics Committees of the Universities of Newcastle and
Queensland. Informed consent was given by all participants.
Baseline surveys were mailed in 1996, with the first
followup in 1998 and then at intervals of 3 years to
2010. The baseline sample (n = 13,715, response rate
54%) was representative of Australian women in this age
group (22). As the items for PA differed in the first sur-
vey, data from survey 2 (1998) to survey 6 (2010) were
used for this article. The response rates for surveys 2
through 6 were 90.0%, 81.9%, 79.5%, 77.6%, and 73.0%,
respectively. All participants with complete data on
physical activity (1998–2010) and joint symptoms (2010)
were included (Figure 1).
Joint symptoms. In each survey, participants were asked
to indicate the frequency of experiencing joint pain and
stiffness in the last 12 months, with the response options
being never, rarely, sometimes, and often. Having joint
symptoms was defined as having joint pain and stiffness
often at each survey (23). Two outcome variables were
created. Prevalent joint symptoms was defined as reporting
joint symptoms in 2010. For the cumulative incident
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Significance & Innovations
• Examination of physical activity patterns over 12
years in middle-aged women showed that
maintaining at least low levels of physical activ-
ity throughout middle age is required to benefit
from its protective effects on joint symptoms in
later middle age.
• The association between physical activity and
joint symptom protection was modified by body
mass index: the protective effect of physical
activity on joint symptoms was stronger in obese
women than in under- or normal-weight women.
• This association was the same for subgroups
according to menopause and hormone therapy
use status.
• These findings support the use of strategies to
improve physical activity interventions in middle-
aged women to prevent subsequent joint symptoms.
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definition, participants who reported having joint symp-
toms often at the 1998 survey were excluded and those
reporting joint symptoms often at the 2001, 2004, 2007, or
2010 surveys were defined as having cumulative incident
joint symptoms.
PA. PA level was assessed at surveys 2–6 (1998–2010)
using a modified version of the Active Australia question-
naire, which has acceptable measurement properties (test–
retest correlation = 0.64, correlation with accelerometry =
0.52) (24). Participants were asked to report the duration, in
the last week, of walking (for recreation, exercise, or
transportation), moderate-intensity leisure-time activities
(e.g., social tennis, recreational swimming, dancing), and
vigorous-intensity leisure-time activities (activities that
make you breathe harder or puff and pant, e.g., aerobics,
competitive sport). The time spent in each activity (minutes/
week) was multiplied by a metabolic equivalent (MET) score
to reflect the average intensity of the activities in that
category: 3.33 for walking briskly and moderate leisure-time
activities, and 6.66 for vigorous leisure-time activity (25,26).
To estimate PA, the MET minutes/week in each category of
activities were summed. The scores were categorized as
none (<50), low (50 to <500) and meeting PA guidelines
(≥500 MET minutes/week) (27). Participants were classified
into 1 of 4 PA patterns according to their reported levels of
PA at each of the 5 surveys: none or low, low or meeting
guidelines, fluctuating, and meeting guidelines at all times
(reference pattern). For additional details on these
classifications, see Supplementary Table 1, available on the
Arthritis Care & Research web site at http://onlinelibrary.
wiley.com/doi/10.1002/acr.23430/abstract.
Effect modifiers. Patterns of BMI, menopausal status,
and HT use were based on self-reported data from surveys
2–6. At each survey, BMI was calculated using self-reported
weight and height, and categorized as underweight/normal
weight if BMI was <25 kg/m2 on at least 3 surveys, as
overweight if BMI was 25 to <30 kg/m2 on at least 3 surveys,
and as obese if BMI was ≥30 kg/m2 on at least 3 surveys. In
accordance with the 2001 Stages of Reproductive Ageing
Workshop criteria, participants were classified according to
menopausal status at each survey (28). These classifications
plus age at menopause were used to define average (ages >49
to <53 years), late (age ≥53 years), or early (age ≤49 years) age
at menopause, and as oophorectomy + hysterectomy if they
had bilateral oophorectomy with or without hysterectomy or
as hysterectomy only (for details, see Supplementary
Appendix A, available on the Arthritis Care & Research
web site at http://onlinelibrary.wiley.com/doi/10.1002/acr.
23430/abstract). Participants were classified as prolonged
HT users if they reported HT use on 2 or more surveys and
as nonusers/short-term HT users if they reported HT use on
no surveys or 1 survey.
Sociodemographic and health variables. Sociodemo-
graphic and health variables were based on self-report and
measured at survey 2 (except level of education, which was
only asked about at survey 1) and categorized as shown in
Table 1. The number of chronic conditions (range 0–6) was
assessed with the question “In the past 3 years, have you
been diagnosed with or treated for: diabetes mellitus, heart
disease, stroke, asthma/bronchitis, osteoporosis, or cancer?”
Depressive symptoms were assessed using the 10-item
Center for Epidemiologic Studies Depression Scale (range
0–30, with higher scores indicating more symptoms) (29,30).
Copies of the surveys can be obtained from www.alswh.org.
au/for-researchers/surveys.
Statistical analysis. All analyses were done using Stata,
version 11.1. Descriptive statistics were used to summarize
sample characteristics for women in each of the PA pattern
groups. Approximately normally distributed continuous
variables were presented as means and SDs, and group
differences were tested using analysis of variance. Non-
normally distributed continuous variables were presented as
medians and interquartile ranges, and group differences were
tested using the Kruskal-Wallis test. Categorical variables
were presented as percentages, and group differences were
tested using the chi-square test.
Survey 1 (1996): n = 13,715
Survey 2 (1998): n = 12,338 (90.0%)
No. participants included in 
analyses: 6,661 (54.0%)
Excluded were those who: had missing data for joint 
symptoms at survey 6 (2,889, 23.4%), had missing data for 
physical activity at surveys 2, 3, 4, 5, or 6 (1,847, 15.0%), had 
missing data on body mass index, menopausal status, or 
hormone therapy use (631, 5.1%), or had missing data on any 
of the confounders (310, 2.5%).
Excluded were those who: did not do survey 2 (261, 1.9%), 
could not be contacted (857, 6.2%), had withdrawn (209, 
1.5%), or died (50, 0.4%).
Figure 1. Flow chart of participants in the Australian Longitudinal Study on Women’s Health included in the current analyses.
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The association between PA patterns (1998–2010) and
joint symptoms (2010) was analyzed using logistic regres-
sion. The analyses were performed for both prevalent and
incident joint symptoms. Potential interaction with BMI,
menopausal status, and HT use was examined by including
a product term of each with the PA patterns and comparing
the models with and without the product terms in terms of
model fit using the likelihood ratio test. Potential collinear-
ity between menopausal status and HT use was checked
but not confirmed (variance inflation factors <1.1; 43.1% of
those with oophorectomy/hysterectomy used HT). Next,
the model was fitted for BMI strata, menopausal status, and
HT use. Potential confounders were selected based on pre-
vious studies and included age, marital status, level of edu-
cation, employment status, smoking status, chronic
conditions, and depressive symptoms (2,31–35). The asso-
ciation was adjusted for confounders (measured in 1998)
that changed the regression coefficient by more than 10%,
which was the case for depressive symptoms and level of
education. The main analyses included data from women
with complete data. As 309 participants had missing values
on at least 1 of the potential confounders, multiple imputa-
tion by chained equations was used to impute these miss-
ing values (36,37). Sensitivity analyses were done to
examine the effect of exclusion due to missing values. An
alpha level of 0.01 was set to account for multiple testing,
and the data were expressed as odds ratios (ORs) with 99%
confidence intervals (99% CIs).
RESULTS
Based on 1998–2010 data, the 6,661 included participants
were classified by their PA participation as follows: none or
low (n = 504), fluctuating (n = 2,285), low or meeting guide-
lines (n = 2,472), and meeting guidelines at all times (n =
1,400) (Table 1). In 1998, the 4 groups did not differ in age
(P = 0.54) and the participants had a mean  SD age of 49.5
 1.5 years. Participants in the none or low and fluctuating
groups were less likely to live in urban areas, less likely to
have post–high school education, more likely to be current
smokers, more likely to have chronic conditions, and had
more depressive symptoms than participants in the low or
meeting guidelines or meeting guidelines at all times
groups (P ≤ 0.001). At study baseline, the none or low and
fluctuating groups were also more likely to be obese, to
have had oophorectomy and/or hysterectomy, and to use
HT (P < 0.001). At the end of the followup in 2010, the
prevalence of joint symptoms was markedly higher in the
none or low (36.6%) and fluctuating (32.2%) groups than
in the low or meeting guidelines (21.2%) and the meeting
guidelines at all times (19.9%) groups (P < 0.001) (Fig-
ure 2).
Table 1. Sample characteristics in 1998*
Characteristic
Physical activity pattern 1998–2010
PNone/low Fluctuating Low/MG MG
No. (%) 504 (7.6) 2,285 (34.3) 2,472 (37.1) 1,400 (21.0)
Age, mean  SD years 49.4  1.4 49.5  1.4 49.5  1.5 49.5  1.5 0.54
Living in urban areas 33.7 31.8 36.8 38.7 < 0.001
Married/de facto relationship 83.7 83.7 85.4 84.9 0.40
Level of education < 0.001
No formal education 18.5 17.6 10.8 9.2
Less than high school 39.1 33.9 29.3 29.8
High school 13.1 17.5 17.8 15.2
Trade/certificate/diploma 18.3 19.4 21.6 24.8
University 11.1 11.5 20.5 21.0
Paid work 59.7 59.5 63.2 60.7 0.05
Current smoker 19.8 17.2 12.2 9.5 < 0.001
No. chronic conditions, % ≥1 34.9 31.4 28.8 26.1 < 0.001
Depressive symptoms, median (IQR) 6 (3–10) 5 (3–10) 4 (2–8) 4 (1–7) < 0.001
Joint symptoms 27.8 24.0 15.5 12.7 < 0.001
Body mass index < 0.001
Under/normal weight 34.0 41.4 52.2 59.8
Overweight 32.8 32.6 32.2 28.7
Obese 33.2 26.0 15.6 11.4
Menopausal status 0.004
Premenopause 34.0 34.0 34.5 37.0
Perimenopause 25.5 24.3 26.7 27.0
Postmenopause 11.7 14.0 14.8 12.7
Oophorectomy + hysterectomy† 10.7 8.6 7.1 6.4
Hysterectomy only 18.1 19.7 16.9 16.8
Hormone therapy 28.8 23.5 21.3 18.5 < 0.001
Physical activity, median (IQR)‡ 0 (0–200) 400 (0–999) 600 (300–1,032) 1,399 (899-2,198) < 0.001
* Values are percentages unless otherwise indicated. MG = meeting guidelines; IQR = interquartile range.
† Includes women who had oophorectomy only (n = 40, 5.4%).
‡ In metabolic equivalent minutes/week.
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After adjustment for BMI patterns, menopausal status,
and HT use, and the confounders, the fluctuating group (OR
1.34 [99% CI 1.04–1.72]) and the none or low PA group (OR
1.60 [99% CI 1.08–2.35]) had higher odds of incident joint
symptoms than those who were meeting guidelines at all
times (Table 2). In the same model, overweight and obese
participants had higher odds of reporting joint symptoms
than underweight/normal-weight participants. Also, par-
ticipants using HT and those with hysterectomy only had
higher odds of reporting joint symptoms than nonusers and
participants with average age at menopause, respectively.
Repeating these analyses for prevalent joint symptoms in
2010 yielded similar results for PA patterns, BMI, and HT
use (Table 2). In addition, oophorectomy and/or hysterec-
tomy were also associated with prevalent joint symptoms.
Adding the product term of PA pattern and BMI signif-
icantly improved the model fit (likelihood ratio test P ≤
0.01). Stratification by BMI showed that the association
between PA pattern and joint symptoms was statistically
significant in the obese group only for incident and
prevalent joint symptoms (Table 3).
Adding the product term of PA pattern and menopausal
status did not significantly improve the model fit (likeli-
hood ratio test P ≥ 0.27). Stratification by menopausal status
Figure 2. Prevalence of joint symptoms at each time point by pattern of physical activity over time (1998–2010). Figure based on data
from women with complete data on physical activity and joint symptoms at all time points.
Table 2. Associations between patterns of physical activity, BMI, menopausal status, and HT use and joint symptoms in the
total sample (n = 6,661)*
Prevalent joint symptoms in 2010
Cumulative incident joint
symptoms 1998–2010
No. (%)† OR (99% CI) P No. (%)† OR (99% CI) P
Physical activity pattern
MG at all times 1,400 (19.7) 1 873 (32.1) 1
Low or MG 2,472 (21.2) 0.99 (0.79–1.23) 0.87 1,478 (32.6) 0.92 (0.72–1.17) 0.35
Fluctuating 2,285 (32.2) 1.43 (1.14–1.78) < 0.001 1,246 (45.4) 1.34 (1.04–1.72) 0.003
None or low 504 (36.9) 1.61 (1.18–2.20) < 0.001 262 (51.9) 1.60 (1.08–2.35) 0.002
BMI pattern
Under/normal weight 2,759 (18.6) 1 1,665 (29.6) 1
Overweight 2,240 (26.2) 1.48 (1.24–1.78) < 0.001 1,344 (39.4) 1.49 (1.22–1.84) < 0.001
Obese 1,662 (37.4) 2.12 (1.75–2.56) < 0.001 850 (52.0) 2.26 (1.78–2.86) < 0.001
Menopausal status pattern
Average age at menopause 1,631 (20.1) 1 1,000 (32.5) 1
Early age at menopause 1,103 (24.7) 1.19 (0.92–1.52) 0.08 635 (36.7) 1.08 (0.81–1.44) 0.48
Late age at menopause 1,807 (22.1) 1.15 (0.92–1.44) 0.11 1,122 (35.2) 1.11 (0.87–1.42) 0.28
Oophorectomy + hysterectomy 740 (36.5) 1.57 (1.19–2.08) < 0.001 369 (49.1) 1.38 (0.97–1.97) 0.02
Hysterectomy only 1,380 (32.8) 1.53 (1.21–1.93) < 0.001 733 (44.9) 1.36 (1.03–1.79) 0.004
HT pattern
Nonuse/short-term HT use 4,812 (23.1) 1 2,903 (34.8) 1
Prolonged HT use 1,849 (33.1) 1.33 (1.12–1.58) < 0.001 956 (47.5) 1.43 (1.15–1.78) < 0.001
* BMI = body mass index; HT = hormone therapy; OR = odds ratio; 99% CI = 99% confidence interval; MG = meeting guidelines.
† Number of participants per category and percentage of participants reporting joint symptoms in 2010. In addition to the presented variables, the
logistic regression model includes the confounders level of education, depressive symptoms, and chronic conditions.
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showed that there were no statistically significant associa-
tions between PA pattern and joint symptoms within any
of the strata (Table 4).
Adding the product term of PA pattern and HT use did
not significantly improve the model fit (likelihood ratio test
P ≥ 0.17). Stratification by HT use showed that the associa-
tion between PA pattern and joint symptoms was statisti-
cally significant in the HT prolonged users group for
incident joint symptoms and in nonusers/short-term users
group for prevalent joint symptoms (Table 4).
Participants with complete data were more likely to have
higher levels of education than participants with missing
data on confounders (P = 0.001), but there were no statisti-
cally significant differences in other sociodemographic and
health characteristics. After imputation of the missing val-
ues on confounders, no appreciable difference in the ORs
compared with the complete case analysis was found (see
Supplementary Tables 2–4, available on the Arthritis Care
& Research web site at http://onlinelibrary.wiley.com/doi/
10.1002/acr.23430/abstract). Compared with participants
with missing data on any of the variables, those with com-
plete data were more likely to live in urban areas, be mar-
ried, have higher levels of education, be employed, be
nonsmokers, and have a late menopause (P < 0.001). Par-
ticipants with complete data also had fewer depressive
symptoms and chronic conditions (P < 0.001), but there
were no significant differences in the prevalence of joint
symptoms, BMI patterns, or HT use.
DISCUSSION
Examination of PA patterns over 12 years in middle-aged
women showed that consistently throughout middle age
at least low levels of PA are required to benefit from its
protective effects on joint symptoms. The protective
effect of PA on joint symptoms seemed stronger in obese
women than in underweight/normal weight or over-
weight women, and this effect appears unrelated to
menopause status and HT use.
To our knowledge, no other studies have examined the
association between patterns of PA over time and joint
symptoms in this age group. The finding that being physi-
cally active is associated with lower odds of joint symp-
toms is consistent with previous findings from the same
cohort (4,38). As there were no significant differences
between the low or meeting guidelines and the meeting
guidelines at all times groups (Table 2), it seems that doing
at least low levels of PA consistently at each time point is
sufficient for protective effects on joint symptoms. The cur-
rent results further suggest that the low levels of PA need to
be sustained over time to be beneficial.
Although the relationship between high BMI and
increased risk of joint symptoms is well established (39,40),
our findings shed new light on the potential modifying role
of BMI on the association between PA and joint symptoms
in middle-aged women. Contrary to previous studies, which
found no evidence of effect modification by BMI in the asso-
ciation between PA and OA (33,35,41), we found stronger
associations between PA and joint symptoms in the obese
group than in the underweight/normal-weight group. Previ-
ous studies may have been underpowered, however, to
detect significant associations within each of the strata,
because stratification led to small numbers of events in each
category. This finding is particularly of importance, as it
counters the concern that PA may increase the risk of joint
symptoms in obese people due to joint loading.
The relationship between menopausal status and joint
symptoms is less clear. In line with other studies, our
Table 3. Associations between physical activity patterns and joint symptoms fitted for stratification by
body mass index*
PA pattern
Prevalent joint symptoms in 2010
Cumulative incident joint
symptoms 1998–2010
No. (%)† OR (99% CI) P No. (%)† OR (99% CI) P
Under/normal weight
MG at all times 746 (15.6) 1 469 (27.5) 1
Low or MG 1,111 (17.0) 0.99 (0.70–1.39) 0.95 702 (28.1) 0.93 (0.64–1.32) 0.55
Fluctuating 755 (22.8) 1.24 (0.86–1.77) 0.13 462 (33.6) 1.12 (0.76–1.66) 0.46
None or low 147 (23.8) 1.23 (0.68–2.20) 0.37 74 (35.1) 1.16 (0.57–2.35) 0.60
Overweight
MG at all times 456 (22.4) 1 302 (36.4) 1
Low or MG 856 (24.3) 1.07 (0.75–1.54) 0.63 506 (34.1) 0.85 (0.57–1.28) 0.31
Fluctuating 772 (28.4) 1.18 (0.82–1.70) 0.25 460 (45.0) 1.19 (0.79–1.80) 0.28
None or low 156 (37.2) 1.70 (1.00–2.91) 0.01 93 (48.4) 1.45 (0.76–2.76) 0.14
Obese
MG at all times 198 (29.3) 1 115 (39.1) 1
Low or MG 505 (25.0) 0.82 (0.50–1.34) 0.31 289 (41.5) 1.07 (0.59–1.93) 0.77
Fluctuating 758 (45.5) 1.96 (1.24–3.10) < 0.001 350 (60.3) 2.21 (1.23–3.95) < 0.001
None or low 201 (46.3) 1.92 (1.10–3.35) 0.003 97 (66.0) 2.74 (1.28–5.84) 0.001
* PA = physical activity; OR = odds ratio; 99% CI = 99% confidence interval; MG = meeting guidelines.
† Number of participants per category and percentage of participants reporting joint symptoms in 2010. The results are
shown after adjustment for level of education, depressive symptoms, chronic conditions, menopausal status, and hormone
therapy use.
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findings suggest that early or late natural progression
through menopause does not seem to be associated with
the risk of joint symptoms, OA, or OA-related joint replace-
ment surgery (16,42,43). In contrast, in an Italian study of
42,464 women who consulted the clinic for menopausal
problems, those who were postmenopausal were more
likely to report having been diagnosed with and treated for
OA (OR 1.18 [95% CI 1.08–1.28) (9). It may be that the nega-
tive current and previous findings were underpowered to
detect a small effect of natural menopause on joint health.
Alternatively, as the Italian study involved cross-sectional
analyses of data from a selective sample of women experi-
encing menopausal problems, their results may not be gen-
eralizable to the general female population.
Women with hysterectomy and oophorectomy had
higher risks of having (i.e., prevalence) and developing
(i.e., incidence) joint symptoms than women with natural
menopause. These findings are in line with those from a
case–control study (11) and possibly lend support to the
hypothesis that estrogen deprivation increases the risk of
developing OA. If this hypothesis is correct, then one
would also expect a protective effect from HT use and from
late menopause on joint symptoms. In contrast, the current
findings suggest a negative association between HT use and
joint symptoms and no association between age at meno-
pause and joint symptoms. These findings are in line with
those of another study of postmenopausal women in which
HT users had higher odds of clinical OA of the hip, hand,
and knee than nonusers (15). An explanation for these find-
ings may be that HT use is a marker for other health prob-
lems, such as a decline in physical functioning (44), that
coincide with joint symptoms. However, other studies have
Table 4. Associations between physical activity patterns and joint symptoms fitted for stratification by menopausal status
and HT use*
Physical activity pattern
Prevalent joint symptoms in 2010
Cumulative incident joint symptoms
1998–2010
No. (%)† OR (99% CI) P No. (%)† OR (99% CI) P
Average age at menopause (49–53 years)
MG at all times 376 (15.2) 1 258 (28.3) 1
Low or MG 619 (16.0) 0.94 (0.58–1.51) 0.72 401 (27.9) 0.86 (0.54–1.38) 0.42
Fluctuating 521 (27.1) 1.57 (0.98–2.50) 0.01 278 (41.4) 1.47 (0.89–2.41) 0.05
None or low 115 (27.0) 1.45 (0.73–2.87) 0.16 63 (39.7) 1.31 (0.60–2.86) 0.37
Early age at menopause (≤49 years)
MG at all times 206 (19.4) 1 129 (30.2) 1
Low or MG 413 (19.1) 0.85 (0.48–1.51) 0.47 237 (33.3) 0.98 (0.52–1.87) 0.95
Fluctuating 400 (30.0) 1.25 (0.71–2.20) 0.30 229 (41.1) 1.18 (0.61–2.26) 0.52
None or low 84 (39.3) 1.78 (0.82–3.88) 0.06 40 (52.5) 1.60 (0.58–4.45) 0.24
Late age at menopause (≥53 years)
MG at all times 404 (16.3) 1 259 (33.6) 1
Low or MG 709 (19.5) 1.18 (0.76–1.83) 0.32 442 (29.9) 0.79 (0.51–1.24) 0.18
Fluctuating 570 (26.7) 1.41 (0.90–2.21) 0.05 344 (39.5) 1.01 (0.63–1.62) 0.94
None or low 124 (34.7) 1.79 (0.95–3.36) 0.02 77 (52.0) 1.43 (0.70–2.92) 0.20
Oophorectomy + hysterectomy
MG at all times 123 (33.3) 1 74 (37.8) 1
Low or MG 250 (28.0) 0.72 (0.39–1.34) 0.18 131 (40.5) 1.04 (0.47–2.34) 0.89
Fluctuating 283 (43.1) 1.26 (0.70–2.27) 0.32 127 (62.2) 2.15 (0.94–4.92) 0.02
None or low 75 (45.3) 1.13 (0.50–2.56) 0.69 37 (56.8) 1.64 (0.53–5.09) 0.26
Hysterectomy only
MG at all times 282 (24.5) 1 153 (34.6) 1
Low or MG 481 (28.5) 1.08 (0.68–1.70) 0.67 257 (39.7) 1.07 (0.61–1.88) 0.75
Fluctuating 511 (39.3) 1.49 (0.95–2.34) 0.02 268 (52.6) 1.54 (0.87–2.72) 0.05
None or low 106 (42.5) 1.66 (0.87–3.16) 0.05 45 (64.4) 2.56 (0.99–6.62) 0.01
Nonuse/short-term HT use
MG at all times 1,046 (16.9) 1 685 (31.0) 1
Low or MG 1,795 (19.5) 1.09 (0.83–1.43) 0.42 1,109 (29.0) 0.83 (0.63–1.10) 0.09
Fluctuating 1,630 (29.1) 1.48 (1.13–1.94) < 0.001 927 (42.3) 1.27 (0.95–1.69) 0.03
None or low 341 (31.4) 1.55 (1.06–2.29) 0.001 182 (45.6) 1.34 (0.84–2.12) 0.10
Prolonged HT use
MG at all times 354 (28.0) 1 188 (36.2) 1
Low or MG 677 (25.6) 0.80 (0.54–1.19) 0.15 369 (43.4) 1.22 (0.75–1.99) 0.30
Fluctuating 655 (39.9) 1.31 (0.90–1.95) 0.07 319 (54.2) 1.61 (0.97–2.68) 0.02
None or low 163 (48.5) 1.70 (1.00–2.89) 0.01 80 (66.3) 2.60 (1.23–5.50) 0.001
* HT = hormone therapy; OR = odds ratio; 99% CI = 99% confidence interval; MG = meeting guidelines.
† Number of participants per category and the percentage of participants reporting joint symptoms in 2010. Results shown are after adjustment for
level of education, depressive symptoms, chronic conditions, and body mass index. The models fitted for stratification by HT use were additionally
adjusted for menopausal status.
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found protective effects of HT use on knee articular carti-
lage (45), radiographic OA (12), and joint replacements
(16). These contrasting findings, from studies with different
measures of joint health, make it difficult to draw any con-
clusions. Further research examining the effects of duration
and type of HT is needed to better understand the associa-
tion between HT use and joint health and the underlying
mechanisms. The current results suggest that the associa-
tion between physical activity and joint symptoms is modi-
fied by BMI, but not by menopausal status or HT use. Given
that the prevalence of joint symptoms was highest (28.2%)
and the proportion of women meeting PA guidelines was
lowest (12.5%) in obese women, promoting PA in this
group appears to be particularly important.
Strengths of this study include the large sample size and
repeated measurements, which allowed for examination of
PA patterns, BMI, menopausal status, HT use, and joint
symptoms over time. However, due to the high prevalence
of joint symptoms at the start of the followup (survey 2)
there were relatively few cases with incident joint symp-
toms. This resulted in limited power to detect statistically
significant associations with incident joint symptoms, par-
ticularly in the stratified analyses. A limitation of the study
is that all measures, including the outcome, are based on
self-report. The outcome is a crude measure of frequency of
any joint pain and stiffness perceived in the past 12
months. Information about which joints were affected or
severity is not available. The strength of the association
between PA and joint symptoms may vary by type of symp-
tom (e.g., pain, swelling, stiffness), by joint, or by severity.
The outcome may have included non-arthritis-related joint
symptoms. We chose to examine joint symptoms rather
than using a formal OA diagnosis, as many women in this
age range may not have been diagnosed formally, using, for
example, medical imaging. Previous research in this sample
showed that fluctuations in joint symptoms coincided with
within-person variation in the self-report of OA (23). Two
definitions of joint symptoms were used: prevalent joint
symptoms (reflecting the presence of symptoms at the end
of the followup, irrespective of symptoms perceived during
followup), and cumulative incident joint symptoms (reflect-
ing the presence of joint symptoms during followup after
the exclusion of those reporting symptoms at the start of the
followup). With either definition, reverse causation cannot
be fully ruled out, as participants may have developed joint
symptoms during followup and subsequently altered their
PA. We considered using a “pure” incident measure of joint
symptoms, reflecting newly reported symptoms at the end
of followup (survey 6) and excluding participants who
reported joint symptoms during followup (surveys 2–5), so
that the outcome followed the exposure. However, this
resulted in the exclusion of a large proportion of the inac-
tive participants, as they were more likely to develop symp-
toms at earlier ages. This then led to skewed results due to
a healthy survivor bias. Self-report of PA may have led to
misclassification due to under- or overreporting. However,
the survey used has been found to have acceptable validity
when compared with accelerometry (correlation = 0.52)
(24). In addition, the definitions of PA patterns used were
driven by statistical criteria more than clinically relevant
criteria. Various definitions of patterns were explored, but
resulted in too many categories with small numbers of par-
ticipants, as at each survey 37–45% of participants changed
from the previous survey in the level of PA they reported
(with 76% of participants changing at any survey interval).
For example, consideration was given to splitting up the
fluctuating group into separate “increasing” and “decreas-
ing” patterns. However, variation within those categories
regarding the timing and amount of increase and decrease,
and the small numbers of participants in each of the cate-
gories, limited meaningful analyses of this classification.
The effect modifiers BMI, menopausal status, and HT use
were measured in 1998 only, and people may have changed
categories during followup. This may have reduced the
contrast between categories. Conversely, creating addi-
tional categories reflecting transitions between categories
over time would have resulted in more categories with
small numbers of participants. The analyses were adjusted
for important confounders; however, residual confound-
ing cannot be ruled out. Finally, the original sample was
representative of Australian women aged 45–50 years, but
with a somewhat higher representation of partnered
women and women with education beyond the high
school level (22). Comparison of women included in the
analyses and those excluded due to missing values on the
confounders did not show any differences in sociodemo-
graphic and health variables. Moreover, sensitivity analy-
ses after imputing missing values on confounders did not
alter the interpretation of the findings. However, most par-
ticipants were excluded due to missing values on joint
symptoms and PA. Compared with participants with any
missing data, including PA and joint symptoms, those
included in the analyses were in better socioeconomic
positions, were healthier, and had healthier lifestyles.
Hence, the current findings represent a somewhat more
affluent and healthier population.
In conclusion, the results suggest that at least low levels
of PA should be maintained throughout middle age for
women to benefit from the protective effects on joint symp-
toms in later middle age. Furthermore, the association
between PA and joint symptoms is modified by BMI, but
not by menopausal status or HT use. Particularly in obese
women, a physically active lifestyle contributes to reducing
the risk of developing joint symptoms.
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